Velan Capital Investment Management LP Context Therapeutics Inc. Transaction History
Velan Capital Investment Management LP
- $58.2 Million
- Q2 2025
A detailed history of Velan Capital Investment Management LP transactions in Context Therapeutics Inc. stock. As of the latest transaction made, Velan Capital Investment Management LP holds 100,000 shares of CNTX stock, worth $68,000. This represents 0.11% of its overall portfolio holdings.
Number of Shares
100,000
Previous 90,000
11.11%
Holding current value
$68,000
Previous $54,000
22.22%
% of portfolio
0.11%
Previous 0.09%
Shares
3 transactions
Others Institutions Holding CNTX
# of Institutions
43Shares Held
76.2MCall Options Held
0Put Options Held
0-
Bio Impact Capital LLC Cambridge, MA14.7MShares$10 Million1.9% of portfolio
-
Avidity Partners Management LP Dallas, TX7.48MShares$5.08 Million1.33% of portfolio
-
Nextech Invest Ag7.42MShares$5.05 Million1.37% of portfolio
-
Deep Track Capital, LP Greenwich, CT7.42MShares$5.05 Million0.17% of portfolio
-
Nextech Invest, Ltd. Zurich, V87.42MShares$5.05 Million0.92% of portfolio
About Context Therapeutics Inc.
- Ticker CNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 15,966,100
- Market Cap $10.9M
- Description
- Context Therapeutics Inc., a clinical-stage biopharmaceutical company, develops products for the treatment of cancer for women in the United States. Its lead product candidate is onapristone extended release (ONA-XR), a potent and selective antagonist of the progesterone receptor that is linked to resistance for various classes of cancer therape...